{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T01:34:22Z","timestamp":1775957662040,"version":"3.50.1"},"reference-count":57,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2023.11973","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:48:21Z","timestamp":1682077701000},"source":"Crossref","is-referenced-by-count":10,"title":["SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial\u2011mesenchymal transition and PI3K\/AKT pathway activation"],"prefix":"10.3892","volume":"25","author":[{"given":"Xiaoli","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Hematology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfen","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjian","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"key20230526101646_b1-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"key20230526101646_b2-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1056\/NEJMoa1402551","article-title":"Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma","volume":"371","author":"Benboubker","year":"2014","journal-title":"N Eng J Med"},{"key":"key20230526101646_b3-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1056\/NEJMoa1112704","article-title":"Continuous lenalidomide treatment for newly diagnosed multiple myeloma","volume":"366","author":"Palumbo","year":"2012","journal-title":"N Engl J Med"},{"key":"key20230526101646_b4-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1182\/blood-2010-08-303487","article-title":"Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: A randomized Southwest oncology group trial (S0232)","volume":"116","author":"Zonder","year":"2010","journal-title":"Blood"},{"issue":"1009","key":"key20230526101646_b5-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28515-1","article-title":"Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma","volume":"13","author":"Ng","year":"2022","journal-title":"Nat Commun"},{"key":"key20230526101646_b6-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000015220","article-title":"Assignment of a novel bifurcated SET domain gene, SETDB1, to human chromosome band 1q21 by in situ hybridization and radiation hybrids","volume":"84","author":"Harte","year":"1999","journal-title":"Cytogenet Cell Genet"},{"key":"key20230526101646_b7-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3906\/biy-1903-71","article-title":"Knockdown of SET domain, Bifurcated 1 suppresses head and neck cancer cell viability and wound-healing ability in vitro","volume":"43","author":"\u00d6zda\u015f","year":"2019","journal-title":"Turk J Biol"},{"issue":"573515","key":"key20230526101646_b8-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.573515","article-title":"SETDB1 overexpression sets an intertumoral transcriptomic divergence in non-small cell lung carcinoma","volume":"11","author":"Kang","year":"2020","journal-title":"Front Genet"},{"key":"key20230526101646_b9-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3892\/or.2018.6871","article-title":"SETDB1 induces epithelial-mesenchymal transition in breast carcinoma by directly binding with Snail promoter","volume":"41","author":"Yang","year":"2019","journal-title":"Oncol Rep"},{"key":"key20230526101646_b10-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.2147\/OTT.S220700","article-title":"Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"key20230526101646_b11-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"22123","DOI":"10.18632\/oncotarget.25204","article-title":"PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia","volume":"9","author":"Ropa","year":"2018","journal-title":"Oncotarget"},{"key":"key20230526101646_b12-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00432-018-2733-2","article-title":"Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer","volume":"144","author":"Carvalho","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"issue":"e24090","key":"key20230526101646_b13-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24090","article-title":"Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma","volume":"36","author":"Wang","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"key20230526101646_b14-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41556-018-0266-1","article-title":"SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis","volume":"21","author":"Wang","year":"2019","journal-title":"Nat Cell Biol"},{"key":"key20230526101646_b15-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41556-018-0261-6","article-title":"AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions","volume":"21","author":"Guo","year":"2019","journal-title":"Nat Cell Biol"},{"key":"key20230526101646_b16-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1196\/annals.1397.012","article-title":"Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells","volume":"1095","author":"Kim","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key20230526101646_b17-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10555-016-9637-x","article-title":"PI3K\/AKT\/mTOR: Role in breast cancer progression, drug resistance, and treatment","volume":"35","author":"Guerrero-Zotano","year":"2016","journal-title":"Cancer Metastasis Rev"},{"issue":"4507","key":"key20230526101646_b18-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124507","article-title":"The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling","volume":"21","author":"Shorning","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20230526101646_b19-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1182\/bloodadvances.2019001393","article-title":"AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma","volume":"4","author":"Bloedjes","year":"2020","journal-title":"Blood Adv"},{"key":"key20230526101646_b20-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41374-018-0114-8","article-title":"Overexpression of HIF-1\u03b1 contributes to melphalan resistance in multiple myeloma cells by activation of ERK1\/2, Akt, and NF-\u03baB","volume":"99","author":"Tsubaki","year":"2019","journal-title":"Lab Invest"},{"key":"key20230526101646_b21-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3892\/or.2019.6968","article-title":"The PI3K\/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol Rep"},{"key":"key20230526101646_b22-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.leukres.2013.08.015","article-title":"The clinical significance of cereblon expression in multiple myeloma","volume":"38","author":"Schuster","year":"2014","journal-title":"Leuk Res"},{"key":"key20230526101646_b23-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1182\/blood-2016-02-698092","article-title":"Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes","volume":"128","author":"Kort\u00fcm","year":"2016","journal-title":"Blood"},{"key":"key20230526101646_b24-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood-2014-02-557819","article-title":"Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma","volume":"124","author":"Zhu","year":"2014","journal-title":"Blood"},{"key":"key20230526101646_b25-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"11009","DOI":"10.1074\/jbc.M110.180208","article-title":"Evidence of a role for activation of Wnt\/beta-catenin signaling in the resistance of plasma cells to lenalidomide","volume":"286","author":"Bjorklund","year":"2011","journal-title":"J Biol Chem"},{"key":"key20230526101646_b26-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/leu.2013.174","article-title":"Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: Therapeutic implications","volume":"28","author":"Bjorklund","year":"2014","journal-title":"Leukemia"},{"key":"key20230526101646_b27-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/leu.2014.238","article-title":"In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone","volume":"29","author":"Ocio","year":"2015","journal-title":"Leukemia"},{"key":"key20230526101646_b28-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"e1003323","key":"key20230526101646_b29-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003323","article-title":"Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the total therapy clinical trials","volume":"17","author":"Danziger","year":"2020","journal-title":"PLoS Med"},{"key":"key20230526101646_b30-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterprofiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"e0116774","key":"key20230526101646_b31-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116774","article-title":"Statistical inference methods for two crossing survival curves: A comparison of methods","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"key20230526101646_b32-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol"},{"issue":"74","key":"key20230526101646_b33-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-74","article-title":"Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer","volume":"8","author":"Uddin","year":"2009","journal-title":"Mol Cancer"},{"key":"key20230526101646_b34-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann Oncol"},{"key":"key20230526101646_b35-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.exphem.2020.09.196","article-title":"Mechanisms of lenalidomide sensitivity and resistance","volume":"91","author":"Martinez-Hoyer","year":"2020","journal-title":"Exp Hematol"},{"key":"key20230526101646_b36-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa070596","article-title":"Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America","volume":"357","author":"Weber","year":"2007","journal-title":"N Engl J Med"},{"key":"key20230526101646_b37-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1182\/blood-2008-12-196238","article-title":"Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma","volume":"114","author":"Richardson","year":"2009","journal-title":"Blood"},{"key":"key20230526101646_b38-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1158\/0008-5472.CAN-20-2906","article-title":"Histone Methyltransferase SETDB1: A common denominator of tumorigenesis with therapeutic potential","volume":"81","author":"Strepkos","year":"2021","journal-title":"Cancer Res"},{"issue":"351","key":"key20230526101646_b39-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2561-6","article-title":"SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression","volume":"11","author":"Cao","year":"2020","journal-title":"Cell Death Dis"},{"key":"key20230526101646_b40-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/14728222.2017.1279604","article-title":"Emerging role of SETDB1 as a therapeutic target","volume":"21","author":"Karanth","year":"2017","journal-title":"Expert Opin Ther Targets"},{"issue":"e922982","key":"key20230526101646_b41-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.922982","article-title":"High SET domain Bifurcated 1 (SETDB1) expression predicts poor prognosis in breast carcinoma","volume":"26","author":"Zhou","year":"2020","journal-title":"Med Sci Monit"},{"key":"key20230526101646_b42-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.5568","article-title":"SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression","volume":"253","author":"Shang","year":"2021","journal-title":"J Pathol"},{"key":"key20230526101646_b43-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/carcin\/bgz131","article-title":"Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1\/CDK6 axis","volume":"41","author":"Yu","year":"2020","journal-title":"Carcinogenesis"},{"issue":"119522","key":"key20230526101646_b44-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119522","article-title":"HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K\/AKT\/mTOR signaling pathway","volume":"278","author":"Guo","year":"2021","journal-title":"Life Sci"},{"issue":"173008","key":"key20230526101646_b45-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173008","article-title":"Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-alpha\/VEGF, IGF-1\/PI3K\/AKT, and FGF-1\/ANG-2 signaling pathways","volume":"873","author":"Bakr","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"key20230526101646_b46-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.2147\/OTT.S193507","article-title":"Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6\/PI3K\/AKT pathway","volume":"12","author":"Chen","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"206","key":"key20230526101646_b47-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03510-4","article-title":"Suppression of steroid 5alpha-reductase type I promotes cellular apoptosis and autophagy via PI3K\/Akt\/mTOR pathway in multiple myeloma","volume":"12","author":"Dou","year":"2021","journal-title":"Cell Death Dis"},{"key":"key20230526101646_b48-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"13063","DOI":"10.2147\/OTT.S270090","article-title":"Novel small molecular compound AE-848 potently induces human multiple myeloma cell apoptosis by modulating the NF-kappaB and PI3K\/Akt\/mTOR signaling pathways","volume":"13","author":"Xu","year":"2020","journal-title":"Onco Targets Ther"},{"key":"key20230526101646_b49-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1080\/10428194.2017.1421760","article-title":"PI3K\/AKT\/mTOR pathway in multiple myeloma: from basic biology to clinical promise","volume":"59","author":"Ramakrishnan","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"key20230526101646_b50-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.21037\/tcr-19-2116","article-title":"Preliminary study on the relationship among stem cell markers, drug resistance and PI3K signaling pathway in multiple myeloma (MM) cell","volume":"9","author":"Li","year":"2020","journal-title":"Transl Cancer Res"},{"key":"key20230526101646_b51-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11684-018-0656-6","article-title":"Epithelial-to-mesenchymal transition in cancer: Complexity and opportunities","volume":"12","author":"Zhang","year":"2018","journal-title":"Front Med"},{"key":"key20230526101646_b52-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res"},{"key":"key20230526101646_b53-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10555-009-9194-7","article-title":"Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer","volume":"28","author":"McConkey","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"key20230526101646_b54-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3892\/ijo.2015.3084","article-title":"Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)","volume":"47","author":"Huang","year":"2015","journal-title":"Int J Oncol"},{"key":"key20230526101646_b55-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"898","DOI":"10.14348\/molcells.2016.0210","article-title":"Highly expressed integrin-\u03b18 induces epithelial to mesenchymal transition-like features in multiple myeloma with early relapse","volume":"39","author":"Ryu","year":"2016","journal-title":"Mol Cells"},{"issue":"117503","key":"key20230526101646_b56-ETM-25-6-11973","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117503","article-title":"IGF-1 promotes multiple myeloma progression through PI3K\/Akt-mediated epithelial-mesenchymal transition","volume":"249","author":"Peng","year":"2020","journal-title":"Life Sci"},{"key":"key20230526101646_b57-ETM-25-6-11973","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2020.05.029","article-title":"Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer","volume":"487","author":"Hou","year":"2020","journal-title":"Cancer Lett"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T10:19:22Z","timestamp":1685096362000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2023.11973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,4,21]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2023.11973","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"article-number":"274"}}